EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study

Xinhai Huang, Wenlin Xu, Guilan Wu, Ruijuan Li, Ping Gu, Qiaowei Zheng, Xiumei Liu, Hengfen Dai, Xiangsheng Lin, Yuxin Liu, Xiaoming Du, Jun Su und 6 weitere

European Journal of Clinical Pharmacology · 2024

DOI: 10.1007/s00228-024-03689-3 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Clinical Pharmacology, 2024. Verfasst von Xinhai Huang und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Dabigatran, Rivaroxaban, Atrial Fibrillation, Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DabigatranRivaroxabanAtrial FibrillationHemorrhageHumansMaleFemaleAgedRetrospective StudiesMiddle AgedAntithrombinsStrokeFactor Xa InhibitorsAged, 80 and overThromboembolism

Stichwörter der Autor:innen

Atrial fibrillationBleedingDirect oral anticoagulantImpaired liver functionThromboembolism

Substanzen

DabigatranRivaroxabanAntithrombinsFactor Xa Inhibitors

Autor:innen und Institutionen

  • School of Pharmacy, Fujian Medical University, Fuzhou, China.
  • Department of Pharmacy, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, #18 Daoshan Road, Fuzhou, 350001, China.
  • Department of Pharmacy, Tongji Shanxi Hospital, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China.
  • Department of Pharmacy, Suining Central Hospital, Suining, Sichuan, 629000, China.
  • Department of Pharmacy, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Pharmacy, People's Hospital of He'nan University of Chinese Medicine, People's Hospital of Zhengzhou), Zhengzhou, China.

Zitieren

APA

Huang, X., Xu, W., Wu, G., Li, R., Gu, P., Zheng, Q., Liu, X., Dai, H., Lin, X., Liu, Y., Du, X., Su, J., Zhang, W., Zhang, M., Zhu, Z., Huang, X., Huang, N., & Zhang, J. (2024). Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03689-3

Vancouver

Huang X, Xu W, Wu G, Li R, Gu P, Zheng Q, et al. Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study. European Journal of Clinical Pharmacology. 2024. doi:10.1007/s00228-024-03689-3

BibTeX
@article{Huang2024,
  author = {Huang, Xinhai and Xu, Wenlin and Wu, Guilan and Li, Ruijuan and Gu, Ping and Zheng, Qiaowei and Liu, Xiumei and Dai, Hengfen and Lin, Xiangsheng and Liu, Yuxin and Du, Xiaoming and Su, Jun and Zhang, Wang and Zhang, Min and Zhu, Zhu and Huang, Xiaohong and Huang, Nianxu and Zhang, Jinhua},
  title = {Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study},
  journal = {European Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1007/s00228-024-03689-3}
}
Kostenlos starten →